Stephen W. Kidder’s Vertex Pharmaceuticals VRTX Stock Holding History

Stephen W. Kidder’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.68M	Buy	12,716 +257	+2%	+$120K	1.67%	24
2025 Q4	$5.65M	Buy	12,459 +161	+1%	+$69.4K	1.59%	22
2025 Q3	$4.82M	Buy	12,298 +168	+1%	+$70.2K	1.38%	24
2025 Q2	$5.4M	Buy	12,130 +164	+1%	+$75.6K	1.62%	24
2025 Q1	$5.8M	Buy	11,966 +1,718	+17%	+$801K	1.81%	25
2024 Q4	$4.13M	Buy	10,248 +2,544	+33%	+$1.18M	1.24%	26
2024 Q3	$3.58M	Buy	7,704 +3,145	+69%	+$1.51M	1.06%	29
2024 Q2	$2.14M	Buy	4,559 +3,986	+696%	+$1.73M	0.67%	33
2024 Q1	$240K	Buy	+573	New	+$242K	0.08%	68

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Stephen W. Kidder's VRTX Position: Q1 2026 in Review

Stephen W. Kidder increased its Vertex Pharmaceuticals (VRTX) stake by 2.1% in Q1 2026, buying an estimated $120K and bringing the position to 12,716 shares worth $5.68M. The position accounts for 1.67% of the portfolio, ranked #24.

Stephen W. Kidder first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.8M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Stephen W. Kidder held 12,716 shares of Vertex Pharmaceuticals worth $5.68M as of Q1 2026.
Stephen W. Kidder bought 257 Vertex Pharmaceuticals shares in Q1 2026, an estimated $120K.
Vertex Pharmaceuticals made up 1.67% of Stephen W. Kidder's portfolio in Q1 2026, its #24 holding.
Stephen W. Kidder first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Stephen W. Kidder's Vertex Pharmaceuticals position peaked at $5.8M in Q1 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Stephen W. Kidder's 13F filing for Q1 2026, filed 11 May 2026.